HLB Life Science Co., Ltd. (KOSDAQ:067630)
4,520.00
+335.00 (8.00%)
Oct 8, 2026, 3:30 PM KST
| Market Cap | 550.75B +37.8% |
| Revenue (ttm) | 54.40B +37.9% |
| Net Income | -33.11B |
| EPS | -272.17 |
| Shares Out | 121.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 712,874 |
| Open | 4,300.00 |
| Previous Close | 4,185.00 |
| Day's Range | 4,300.00 - 4,600.00 |
| 52-Week Range | 1,608.00 - 5,330.00 |
| Beta | 0.13 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |